Literature DB >> 21248086

Comparison of nine phenotypic methods for detection of extended-spectrum beta-lactamase production by Enterobacteriaceae.

Hélène Garrec1, Laurence Drieux-Rouzet, Jean-Louis Golmard, Vincent Jarlier, Jérôme Robert.   

Abstract

The detection of extended-spectrum β-lactamase-producing (ESBL) bacteria is of importance for infection control and epidemiological surveillance. We aimed to compare phenotypic methods available in the routine laboratory and to evaluate two-step strategies using these methods for the detection of ESBL-positive Enterobacteriaceae. Two methods used for routine susceptibility testing (Vitek2 and disk diffusion methods) and seven methods designed for the detection of ESBL production (ESBL Etests, combination disks, double-disk synergy [DDS] methods on Mueller-Hinton [MH] agar and cloxacillin-containing MH agar, and the Cica-Beta test) were tested against 107 strains of Enterobacteriaceae not susceptible to extended-spectrum cephalosporins. All strains were screened for the presence of acquired ESBL-encoding genes by PCR, and the PCR result was considered the gold standard for evaluation of the other test methods. Among the 107 strains, 52 (49%) were ESBL positive. With Vitek2, sensitivities were the highest when using extended cards (73% to 79%), but 25% to 31% of the strains yielded indeterminate results. For the disk diffusion method, sensitivities were the highest (96%) when testing at least cefotaxime, cefepime, and a third compound (ceftazidime, cefpodoxime, or aztreonam). For the specific methods, specificities ranged from 62% (ceftazidime ESBL Etest) to 100% (DDS using a disk spacing of 20 mm). When a method designed for ESBL detection was used on strains considered ESBL negative or with an indeterminate result by a first routine susceptibility method, sensitivities reached 100% for a majority of combinations. In conclusion, two-step strategies using phenotypic methods available in most clinical laboratories may reach a sensitivity of 100% for ESBL detection among a large panel of species, including AmpC producers, providing a sensible choice of tests.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21248086      PMCID: PMC3067698          DOI: 10.1128/JCM.02130-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

1.  Detection of extended-spectrum beta-lactamases in members of the family enterobacteriaceae: comparison of the MAST DD test, the double disc and the Etest ESBL.

Authors:  F H M'Zali; A Chanawong; K G Kerr; D Birkenhead; P M Hawkey
Journal:  J Antimicrob Chemother       Date:  2000-06       Impact factor: 5.790

2.  Detection of extended-spectrum beta-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes.

Authors:  E Tzelepi; P Giakkoupi; D Sofianou; V Loukova; A Kemeroglou; A Tsakris
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 3.  Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes.

Authors:  R Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

4.  Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretive reading of antimicrobial resistance tests.

Authors:  D M Livermore; M Struelens; J Amorim; F Baquero; J Bille; R Canton; S Henning; S Gatermann; A Marchese; H Mittermayer; C Nonhoff; K J Oakton; F Praplan; H Ramos; G C Schito; J Van Eldere; J Verhaegen; J Verhoef; M R Visser
Journal:  J Antimicrob Chemother       Date:  2002-02       Impact factor: 5.790

5.  Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.

Authors:  V Jarlier; M H Nicolas; G Fournier; A Philippon
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

6.  Detection of extended-spectrum beta-lactamases in klebsiellae with the Oxoid combination disk method.

Authors:  M W Carter; K J Oakton; M Warner; D M Livermore
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

7.  Evaluation of Oxoid combination discs for detection of extended-spectrum beta-lactamases.

Authors:  Yves De Gheldre; Véronique Avesani; Catherine Berhin; Michel Delmée; Youri Glupczynski
Journal:  J Antimicrob Chemother       Date:  2003-09-12       Impact factor: 5.790

8.  Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection.

Authors:  Enno Stürenburg; Ingo Sobottka; Djahesh Noor; Rainer Laufs; Dietrich Mack
Journal:  J Antimicrob Chemother       Date:  2004-05-18       Impact factor: 5.790

9.  Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital.

Authors:  Laurent Poirel; Olivier Menuteau; Nathalie Agoli; Christian Cattoen; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

10.  Increase in hospital-acquired bloodstream infections caused by extended spectrum beta-lactamase-producing Escherichia coli in a large French teaching hospital.

Authors:  L Drieux; F Brossier; O Duquesnoy; A Aubry; J Robert; W Sougakoff; M Lecso-Bornet; V Jarlier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-11-12       Impact factor: 3.267

View more
  42 in total

1.  Characterization of the First OXA-10 Natural Variant with Increased Carbapenemase Activity.

Authors:  Stathis D Kotsakis; Carl-Fredrik Flach; Mohammad Razavi; D G Joakim Larsson
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

2.  In vitro interaction between cefepime and amoxicillin-clavulanate against extended-spectrum β-lactamase-producing Escherichia coli.

Authors:  Edouard Bingen; Philippe Bidet; Camille D'humières; Elsa Sobral; Patricia Mariani-Kurkdjian; Robert Cohen
Journal:  Antimicrob Agents Chemother       Date:  2013-05       Impact factor: 5.191

3.  Virulence and Antibiotic Resistance Patterns in E. coli, Morocco.

Authors:  Abouddihaj Barguigua; Hamid Rguibi Idrissi; Kaoutar Nayme; Mohammed Timinouni
Journal:  Ecohealth       Date:  2019-03-20       Impact factor: 3.184

4.  Efficacy of cefoxitin versus carbapenem in febrile male urinary tract infections caused by extended spectrum beta-lactamase-producing Escherichia coli: a multicenter retrospective cohort study with propensity score analysis.

Authors:  O Senard; M Lafaurie; P Lesprit; Y Nguyen; X Lescure; A Therby; V Fihman; N Oubaya; R Lepeule
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-09-11       Impact factor: 3.267

5.  Modified CLSI extended-spectrum β-lactamase (ESBL) confirmatory test for phenotypic detection of ESBLs among Enterobacteriaceae producing various β-lactamases.

Authors:  Aggeliki Poulou; Evgenia Grivakou; Georgia Vrioni; Vassiliki Koumaki; Theodoros Pittaras; Spyros Pournaras; Athanassios Tsakris
Journal:  J Clin Microbiol       Date:  2014-02-26       Impact factor: 5.948

6.  Comparative Study of ESBL Production Among Uropathogenic Escherichia coli Clinical Isolates from Pre- and Post-menopausal Women in Egypt.

Authors:  Ghada Hani Ali; Marwa A Yakout
Journal:  Curr Microbiol       Date:  2021-07-20       Impact factor: 2.188

7.  Evaluation of the βLacta test, a rapid test detecting resistance to third-generation cephalosporins in clinical strains of Enterobacteriaceae.

Authors:  Aurélie Renvoisé; Dominique Decré; Rishma Amarsy-Guerle; Te-Din Huang; Christelle Jost; Isabelle Podglajen; Laurent Raskine; Nathalie Genel; Pierre Bogaerts; Vincent Jarlier; Guillaume Arlet
Journal:  J Clin Microbiol       Date:  2013-09-25       Impact factor: 5.948

8.  Comparison of different phenotypic assays for the detection of extended-spectrum β-lactamase production by inducible AmpC-producing Gram-negative bacilli.

Authors:  E Willems; R Cartuyvels; K Magerman; M Raymaekers; J Verhaegen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-11-08       Impact factor: 3.267

9.  Phenotypic Tests for the Detection of β-Lactamase-Producing Enterobacteriaceae Isolated from Different Environments.

Authors:  Daniele V de Oliveira; Sueli T Van Der Sand
Journal:  Curr Microbiol       Date:  2016-04-12       Impact factor: 2.188

10.  The Molecular and Clinical Epidemiology of Extended-Spectrum Cephalosporin- and Carbapenem-Resistant Enterobacteriaceae at 4 US Pediatric Hospitals.

Authors:  Danielle M Zerr; Scott J Weissman; Chuan Zhou; Matthew P Kronman; Amanda L Adler; Jessica E Berry; Jaipreet Rayar; Jeff Myers; Wren L Haaland; Carey-Ann D Burnham; Alexis Elward; Jason Newland; Rangaraj Selvarangan; Kaede V Sullivan; Theoklis Zaoutis; Xuan Qin
Journal:  J Pediatric Infect Dis Soc       Date:  2017-11-24       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.